Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”
Biomedical Journal · 2026-12 · 49 (6) · 101015
DOI: 10.1016/j.bj.2026.101015 ↗Kurz gefasst
Leserbrief in der Zeitschrift Biomedical Journal, 2026-12. Verfasst von Hui-Ling Huang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Chang Gung Memorial Hospital, Chiayi, Taiwan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Nursing, Chang Gung Memorial Hospital, Chiayi, Taiwan.
- Department of Hepato-Gastroenterology, Division of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan. Electronic address: juten@ms17.hinet.net.
Zitieren
APA
Huang, H. L., & Lu, S. N. (2026). Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”. Biomedical Journal, 49(6), 101015. https://doi.org/10.1016/j.bj.2026.101015
Vancouver
Huang HL, Lu SN. Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”. Biomedical Journal. 2026;49(6):101015. doi:10.1016/j.bj.2026.101015
BibTeX
@article{Huang2026,
author = {Huang, Hui-Ling and Lu, Sheng-Nan},
title = {Response to letter regarding “Co-radiotherapy with tyrosine kinase inhibitors might benefit survival in hepatoma patients with portal vein tumor thrombosis”},
journal = {Biomedical Journal},
year = {2026},
volume = {49},
number = {6},
pages = {101015},
doi = {10.1016/j.bj.2026.101015}
}
EUVIMED